FindTrial
Sign In

Nutritional supplementation in patient with cirrhosis of liver

Prospective study to evaluate the effects of oral branched chain amino acid supplementation on clinical, laboratory parameters, quality of life and the natural course of the disease in patients with cirrhosis of liver

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/03/032164
Enrollment
602
Registered
2021-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: K746- Other and unspecified cirrhosis ofliver

Interventions

None listed

Sponsors

Max Super Speciality Hospital Vaishali
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1-Patients diagnosis with cirrhosis of liver. 2-Patients who are taking/ who are not taking BCCA supplementation

Exclusion criteria

Exclusion criteria: 1-Patients on dietary protein restriction 2-Serum total bilirubin of 3 mg/ dl or higher 3-Hepatocellular carcinoma 4-Resistant ascites 5-Oesohageal varices 6-Hepato encephalopathy grade III or higher

Design outcomes

Primary

MeasureTime frame
1-Any improvement in the serum albumin, pre-albumin levels and clinical nutritional parameters. 2-Occurrence of event free survival- -any occurrence of the following during the course of the disease like a-Hepato encephalopathy b-Variceal bleed c-Spontaneous bacterial peritonitis d-Hepato renal syndrome e-Death 3-Improvement in the Quality of life assessed by SF-36Timepoint: 12 months—

Secondary

MeasureTime frame
-Would be determined on basis of child pug score and MELD score at base line and during follow up -Number of hospital admissions during the course of follow up -duration of hospital stay for the management of any liver related complications. -Overall mortality/survival Timepoint: 12 months—

Countries

India

Contacts

Public ContactDr P Kar

Max Super Specialty Hospital

premashishkar@gmail.com9821839937

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026